Movano Health Advances EvieMED Ring Toward FDA Clearance

Key Insights

• Movano Health is set to respond to the FDA's clarifying questions for its EvieMED Ring, marking a crucial step in the 510(k) clearance process.
• The EvieMED Ring integrates pulse oximetry with wellness metrics, such as sleep and activity tracking, to enhance clinical trials and patient monitoring.
• Movano Health expresses confidence in securing FDA clearance for EvieMED, highlighting its potential to improve patient compliance and data collection.

Movano Health is moving closer to obtaining FDA 510(k) clearance for its EvieMED Ring, a wearable device that combines medical and wellness tracking features. The company plans to submit responses to the FDA's clarifying questions as part of the final review phase.

Having previously addressed initial FDA inquiries regarding EvieMED's wellness features, Movano Health is optimistic about receiving clearance. The EvieMED Ring is designed to provide both medical device functionality through pulse oximetry and comprehensive wellness metrics, including sleep, activity, and mood tracking.

Leadership Optimism

John Mastrototaro, president and CEO of Movano Health, stated, "We are pleased that we will be submitting a timely and thorough response to the agency’s questions and look forward to the successful completion of the 510(k) review process." He emphasized the potential of EvieMED to be a "game-changing device" for remote patient monitoring and clinical trials, enhancing patient compliance and data collection.

EvieMED Ring Features

The EvieMED Ring aims to improve patient compliance and data collection by integrating medical and wellness tracking in a user-friendly design. Its features include pulse oximetry for medical-grade data and tracking of sleep patterns, activity levels, mood, and energy for overall wellness monitoring.